Allergan Inc, the maker of Botox, said on Friday that the U.S. Food and Drug Administration has approved its eyelash-thickening drug Latisse.
Latisse is designed to treat a condition known as hypotrichosis of the eyelashes, which means a person does not have enough eyelashes.
The active ingredient in Latisse is bimatroprost, the same ingredient that is in Allergan's glaucoma treatment Lumigan. Patients taking Lumigan found a side effect of the drug to be eyelash growth, prompting Allergan to study it for the new use.
Latisse is a once-daily prescription treatment that is applied to the base of the upper eyelash with a sterile, single-use-per-eye disposable applicator. Once treatment is stopped, eyelashes will gradually return to where they were prior to treatment.
True, it's more of a treatment than a permanent cure, but even so: No longer will those who suffer from flimsy-eyelash-syndrome (FES) be unable to throw a sultry wink at a handsome man in a three piece suit. No longer will small insects be able to dive into their eye balls like Greg Louganis into a pool. This amazing discovery lashes out at a debilitating affliction that affected dozens of people around the world.
To celebrate this great discovery, here is one of the most stylish videos of all time, Ashford and Simpson's "Found a Cure!"
No comments:
Post a Comment